Research for the molecular imaging of the PD-L1 targeting tracer 18F-WL12

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029354

Enrollment

Unknown

Registered

2020-01-26

Start date

2020-02-01

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

Case series:18F-WL12 PET/CT

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >18 years old; ECoG 0 or 1; 2. Patients with solid tumors; 3. Has at least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST V1.1); 4. life expectancy >=12 weeks.

Exclusion criteria

Exclusion criteria: 1. Significant hepatic or renal dysfunction; 2. Is Pregnant or ready to pregnant; 3. Cannot lie on their back for half an hour; 4. Refusal to join the clinical study; 5. Suffering from claustrophobia or other mental diseases; 6. Any other situation that researchers think it is not suitable to participate in the experiment.

Design outcomes

Primary

Measure	Time frame
SUVmax;	—

Countries

China

Contacts

Public ContactZhu Hua

Beijing Cancer Hospital

zhuhuananjing@163.com+86 010 88196495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026